A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins

The Yellow Fever Vaccine 17D (YFV17D) has been used as a vector for the Lassa virus glycoprotein precursor (LASV-GPC) resulting in construction of YFV17D/LASV-GPC recombinant virus. The virus was replication-competent and processed the LASV-GPC in cell cultures. The recombinant replicated poorly in...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Virology (New York, N.Y.) Ročník 345; číslo 2; s. 299 - 304
Hlavní autori:	Bredenbeek, Peter J., Molenkamp, Richard, Spaan, Willy J.M., Deubel, Vincent, Marianneau, Phillippe, Salvato, Maria S., Moshkoff, Dmitry, Zapata, Juan, Tikhonov, Ilia, Patterson, Jean, Carrion, Ricardo, Ticer, Anysha, Brasky, Kathleen, Lukashevich, Igor S.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Elsevier Inc 20.02.2006
Predmet:	Animals genetic vectors glycoproteins Glycoproteins - genetics Glycoproteins - metabolism Guinea Pigs human health Humans Lassa Fever - prevention & control Lassa mammarenavirus Lassa virus Lassa virus - genetics Lassa virus - immunology Lassa virus - metabolism recombinant fusion proteins Recombinant vaccine vaccines Vaccines, Synthetic - administration & dosage Vaccines, Synthetic - genetics Vaccines, Synthetic - metabolism viral antibodies viral proteins Viral Vaccines - administration & dosage Viral Vaccines - genetics Viral Vaccines - metabolism Yellow and Lassa Fevers yellow fever Yellow Fever - prevention & control Yellow Fever Vaccine - administration & dosage Yellow Fever Vaccine - genetics Yellow Fever Vaccine - metabolism Yellow fever virus Yellow fever virus - immunology YFV17D vaccine Africa YFV17D vaccine Recombinant vaccine Yellow and Lassa Fevers
ISSN:	0042-6822, 1096-0341
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	The Yellow Fever Vaccine 17D (YFV17D) has been used as a vector for the Lassa virus glycoprotein precursor (LASV-GPC) resulting in construction of YFV17D/LASV-GPC recombinant virus. The virus was replication-competent and processed the LASV-GPC in cell cultures. The recombinant replicated poorly in guinea pigs but still elicited specific antibodies against LASV and YFV17D antigens. A single subcutaneous injection of the recombinant vaccine protected strain 13 guinea pigs against fatal Lassa Fever. This study demonstrates the potential to develop an YFV17D-based bivalent vaccine against two viruses that are endemic in the same area of Africa.
AbstractList	The Yellow Fever Vaccine 17D (YFV17D) has been used as a vector for the Lassa virus glycoprotein precursor (LASV-GPC) resulting in construction of YFV17D/LASV-GPC recombinant virus. The virus was replication-competent and processed the LASV-GPC in cell cultures. The recombinant replicated poorly in guinea pigs but still elicited specific antibodies against LASV and YFV17D antigens. A single subcutaneous injection of the recombinant vaccine protected strain 13 guinea pigs against fatal Lassa Fever. This study demonstrates the potential to develop an YFV17D-based bivalent vaccine against two viruses that are endemic in the same area of Africa. The Yellow Fever Vaccine 17D (YFV17D) has been used as a vector for the Lassa virus glycoprotein precursor (LASV-GPC) resulting in construction of YFV17D/LASV-GPC recombinant virus. The virus was replication-competent and processed the LASV-GPC in cell cultures. The recombinant replicated poorly in guinea pigs but still elicited specific antibodies against LASV and YFV17D antigens. A single subcutaneous injection of the recombinant vaccine protected strain 13 guinea pigs against fatal Lassa Fever. This study demonstrates the potential to develop an YFV17D-based bivalent vaccine against two viruses that are endemic in the same area of Africa.The Yellow Fever Vaccine 17D (YFV17D) has been used as a vector for the Lassa virus glycoprotein precursor (LASV-GPC) resulting in construction of YFV17D/LASV-GPC recombinant virus. The virus was replication-competent and processed the LASV-GPC in cell cultures. The recombinant replicated poorly in guinea pigs but still elicited specific antibodies against LASV and YFV17D antigens. A single subcutaneous injection of the recombinant vaccine protected strain 13 guinea pigs against fatal Lassa Fever. This study demonstrates the potential to develop an YFV17D-based bivalent vaccine against two viruses that are endemic in the same area of Africa.
Author	Patterson, Jean Spaan, Willy J.M. Ticer, Anysha Lukashevich, Igor S. Molenkamp, Richard Moshkoff, Dmitry Tikhonov, Ilia Salvato, Maria S. Deubel, Vincent Zapata, Juan Carrion, Ricardo Marianneau, Phillippe Brasky, Kathleen Bredenbeek, Peter J.
Author_xml	– sequence: 1 givenname: Peter J. surname: Bredenbeek fullname: Bredenbeek, Peter J. organization: Department of Medical Microbiology, Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands – sequence: 2 givenname: Richard surname: Molenkamp fullname: Molenkamp, Richard organization: Department of Medical Microbiology, Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands – sequence: 3 givenname: Willy J.M. surname: Spaan fullname: Spaan, Willy J.M. organization: Department of Medical Microbiology, Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands – sequence: 4 givenname: Vincent surname: Deubel fullname: Deubel, Vincent organization: Unité de Biologie des Infectious Virales Emergentes, Centre de Recherche Mériuex-Pasteur á Lyon, Laboratoire P4-Jean Mérieux, Lyon, France – sequence: 5 givenname: Phillippe surname: Marianneau fullname: Marianneau, Phillippe organization: Unité de Biologie des Infectious Virales Emergentes, Centre de Recherche Mériuex-Pasteur á Lyon, Laboratoire P4-Jean Mérieux, Lyon, France – sequence: 6 givenname: Maria S. surname: Salvato fullname: Salvato, Maria S. organization: Institute of Human Virology, University of Maryland Biotechnology Institute, 725 West Lombard Street, Baltimore, MD 21201, USA – sequence: 7 givenname: Dmitry surname: Moshkoff fullname: Moshkoff, Dmitry organization: Institute of Human Virology, University of Maryland Biotechnology Institute, 725 West Lombard Street, Baltimore, MD 21201, USA – sequence: 8 givenname: Juan surname: Zapata fullname: Zapata, Juan organization: Institute of Human Virology, University of Maryland Biotechnology Institute, 725 West Lombard Street, Baltimore, MD 21201, USA – sequence: 9 givenname: Ilia surname: Tikhonov fullname: Tikhonov, Ilia organization: Institute of Human Virology, University of Maryland Biotechnology Institute, 725 West Lombard Street, Baltimore, MD 21201, USA – sequence: 10 givenname: Jean surname: Patterson fullname: Patterson, Jean organization: Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, TX 78245-0549, USA – sequence: 11 givenname: Ricardo surname: Carrion fullname: Carrion, Ricardo organization: Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, TX 78245-0549, USA – sequence: 12 givenname: Anysha surname: Ticer fullname: Ticer, Anysha organization: Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, TX 78245-0549, USA – sequence: 13 givenname: Kathleen surname: Brasky fullname: Brasky, Kathleen organization: Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, TX 78245-0549, USA – sequence: 14 givenname: Igor S. surname: Lukashevich fullname: Lukashevich, Igor S. email: lukashev@umbi.umd.edu organization: Institute of Human Virology, University of Maryland Biotechnology Institute, 725 West Lombard Street, Baltimore, MD 21201, USA
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/16412488$$D View this record in MEDLINE/PubMed
BookMark	eNqFUsFuEzEUtFARTQtfgAR74pbwnr32eoVAqgoFRCQO0AMny3HeBoeNHexNIH-PQ0oFPZCTZb2ZeTOad8ZOQgzE2GOECQKq58vJ1qfYTziAnCCfAOA9NkJo1RhEjSdsBFDzsdKcn7KznJdQ_k0DD9gpqhp5rfWIfbioErm4mvlgw1B9ob6PP6or2lKqsHldba1zPlBFP9eJcvZhUU1tzrYquze5WvQ7F9cpDuRDfsjud7bP9OjmPWfXV28-X74bTz--fX95MR07pXAYO2xk3ZDSCl3dcSxWGq0tl3OFohF8RloJ5zqSTnWd5DPsRCM72-GM2jlocc5eHXTXm9mK5o7CkGxv1smvbNqZaL35dxL8V7OIW4NCa2ihCDy7EUjx-4byYFY-uxLdBoqbbFSjRAtSHgXWJQRIwY8CsQEthRQF-ORv77em_zRSAO0B4FLMOVFnnB_s4OM-iu8Ngtm3b5bmd_tm375Bbkr7hSvucG_l_8t6emB1Nhq7SD6b60-8DABBtUrt0708IKi0uvWUTHaegqO5L8czmHn0Rza8uMN3vQ_e2f4b7Y6yfwHbBueV
CitedBy_id	crossref_primary_10_3390_ph14090891 crossref_primary_10_3390_pathogens7040084 crossref_primary_10_1016_j_antiviral_2007_11_003 crossref_primary_10_1016_j_vaccine_2008_07_057 crossref_primary_10_1128_JVI_00019_09 crossref_primary_10_1186_s12985_024_02585_7 crossref_primary_10_1002_eji_202250133 crossref_primary_10_1016_j_coviro_2019_07_006 crossref_primary_10_1038_s41392_024_01917_x crossref_primary_10_1080_14760584_2016_1184575 crossref_primary_10_1099_vir_0_057000_0 crossref_primary_10_1128_JVI_02876_06 crossref_primary_10_1371_journal_pntd_0003736 crossref_primary_10_1016_j_antiviral_2011_02_012 crossref_primary_10_3390_vaccines1030262 crossref_primary_10_1038_s41541_018_0049_5 crossref_primary_10_1089_vbz_2009_0067 crossref_primary_10_1371_journal_ppat_1003212 crossref_primary_10_3390_vaccines9121492 crossref_primary_10_1016_j_virusres_2020_198000 crossref_primary_10_1128_jvi_00578_24 crossref_primary_10_3390_vaccines11030635 crossref_primary_10_1155_2010_236528 crossref_primary_10_1016_j_vaccine_2007_02_038 crossref_primary_10_3390_vaccines10101668 crossref_primary_10_3390_v11100960 crossref_primary_10_1016_j_micpath_2022_105793 crossref_primary_10_3390_ijms18051040 crossref_primary_10_1016_j_virol_2011_01_013 crossref_primary_10_1016_j_virusres_2011_09_005 crossref_primary_10_1038_s41586_020_3035_9 crossref_primary_10_1093_infdis_jiy123 crossref_primary_10_1016_j_imu_2021_100683 crossref_primary_10_12688_f1000research_16989_1 crossref_primary_10_1038_s41541_023_00699_7 crossref_primary_10_1016_j_antiviral_2011_02_009 crossref_primary_10_1586_14760584_2015_1083430 crossref_primary_10_1016_j_vaccine_2010_11_079 crossref_primary_10_1038_s41541_024_01012_w crossref_primary_10_1016_j_vaccine_2017_12_046 crossref_primary_10_1038_s41541_021_00291_x crossref_primary_10_1099_jgv_0_000026 crossref_primary_10_3390_v4112514 crossref_primary_10_1096_fj_11_193466 crossref_primary_10_1016_j_antiviral_2014_12_010 crossref_primary_10_1186_1743_422X_7_279 crossref_primary_10_1016_j_vaccine_2010_06_052 crossref_primary_10_1586_erv_12_139 crossref_primary_10_1136_bmjgh_2018_001116 crossref_primary_10_1016_j_virol_2014_07_050 crossref_primary_10_1186_1743_422X_10_52 crossref_primary_10_3390_vaccines9101187 crossref_primary_10_1586_14760584_6_2_255 crossref_primary_10_1038_s41541_024_00930_z crossref_primary_10_1517_14712598_8_11_1787 crossref_primary_10_1016_S2222_1808_11_60007_8 crossref_primary_10_1016_j_micinf_2018_01_005 crossref_primary_10_1016_j_vetmic_2009_08_027 crossref_primary_10_1371_journal_pone_0284823 crossref_primary_10_1016_j_omtm_2022_03_010 crossref_primary_10_1016_j_virol_2009_10_033 crossref_primary_10_1016_j_ijid_2022_04_004 crossref_primary_10_1016_j_imlet_2019_03_008 crossref_primary_10_3390_v9040077 crossref_primary_10_2217_fvl_10_65 crossref_primary_10_1038_s41541_020_00219_x
Cites_doi	10.1128/JVI.74.5.2186-2192.2000 10.1128/JVI.74.19.9197-9205.2000 10.1099/vir.0.18860-0 10.1128/JVI.74.23.11418-11421.2000 10.1084/jem.20051352 10.1001/jama.287.18.2391 10.1128/JVI.75.23.11677-11685.2001 10.1128/JVI.79.13.8602-8613.2005 10.1586/14760584.3.2.189 10.1371/journal.pmed.0020183 10.1128/JVI.75.14.6273-6278.2001 10.3201/eid0605.000504 10.1016/j.virol.2005.01.019 10.1084/jem.20041526 10.1038/sj.embor.7400002 10.1128/JVI.79.22.13934-13942.2005
ContentType	Journal Article
Copyright	2005 Elsevier Inc.
Copyright_xml	– notice: 2005 Elsevier Inc.
DBID	6I. AAFTH FBQ AAYXX CITATION CGR CUY CVF ECM EIF NPM 7U9 C1K F1W H94 H97 L.G 7S9 L.6 7X8 5PM
DOI	10.1016/j.virol.2005.12.001
DatabaseName	ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access AGRIS CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Virology and AIDS Abstracts Environmental Sciences and Pollution Management ASFA: Aquatic Sciences and Fisheries Abstracts AIDS and Cancer Research Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality Aquatic Science & Fisheries Abstracts (ASFA) Professional AGRICOLA AGRICOLA - Academic MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Aquatic Science & Fisheries Abstracts (ASFA) Professional Virology and AIDS Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality ASFA: Aquatic Sciences and Fisheries Abstracts Environmental Sciences and Pollution Management AGRICOLA AGRICOLA - Academic MEDLINE - Academic
DatabaseTitleList	AIDS and Cancer Research Abstracts MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	1096-0341
EndPage	304
ExternalDocumentID	PMC1388090 16412488 10_1016_j_virol_2005_12_001 US201301069662 S0042682205008032
Genre	Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural
GeographicLocations	Africa
GeographicLocations_xml	– name: Africa
GrantInformation_xml	– fundername: PHS HHS grantid: R01-A52367 – fundername: NIAID NIH HHS grantid: R01 AI052367
GroupedDBID	--- --K --M -DZ -~X .1- .55 .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29Q 3O- 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABEFU ABFNM ABFRF ABJNI ABMAC ABMZM ABUFD ABXDB ACDAQ ACGFO ACGFS ACIEU ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AEXQZ AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGEKW AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG CJTIS COF CS3 DM4 DU5 EBS EFBJH EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FA8 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEJ HMG HMK HMO HVGLF HX~ HZ~ H~9 IHE IXB J1W KOM LG5 LUGTX LZ5 M29 M41 MO0 MVM N9A O-L O9- OAUVE OD- OHT OK1 OO. OZT P-8 P-9 P2P PC. Q38 Q44 R2- ROL RPZ SAE SCC SDF SDG SDP SES SEW SIN SSH SSI SSZ T5K TN5 UAP UQL WH7 WUQ X7M XOL XPP Y6R Z5R ZGI ZKB ZMT ZU3 ~G- ~HD ~KM 6I. AACTN AAFTH AAIAV ABLVK ABVKL ABYKQ AFCTW AFDAS AFKWA AFMIJ AHPSJ AJBFU AJOXV AMFUW LCYCR NCXOZ RIG ABPIF ABPTK AEQTP FBQ 9DU AAYXX CITATION 0SF CGR CUY CVF ECM EIF NPM 7U9 C1K F1W H94 H97 L.G 7S9 L.6 7X8 5PM
ID	FETCH-LOGICAL-c661t-c17547e6861c4f21412788a25d613732be863ccfe5c6ff52b1f375faf1be9d083
ISICitedReferencesCount	84
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000235468300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0042-6822
IngestDate	Tue Nov 04 01:41:13 EST 2025 Thu Oct 02 11:04:04 EDT 2025 Sat Sep 27 16:04:01 EDT 2025 Wed Oct 01 14:44:44 EDT 2025 Wed Feb 19 01:44:30 EST 2025 Sat Nov 29 07:27:13 EST 2025 Tue Nov 18 22:29:40 EST 2025 Wed Dec 27 19:02:11 EST 2023 Fri Feb 23 02:30:31 EST 2024 Tue Oct 14 19:34:49 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	2
Keywords	YFV17D vaccine Recombinant vaccine Yellow and Lassa Fevers
Language	English
License	http://www.elsevier.com/open-access/userlicense/1.0
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c661t-c17547e6861c4f21412788a25d613732be863ccfe5c6ff52b1f375faf1be9d083
Notes	http://www.sciencedirect.com/science/journal/00426822 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2
OpenAccessLink	https://www.clinicalkey.com/#!/content/1-s2.0-S0042682205008032
PMID	16412488
PQID	17085353
PQPubID	23462
PageCount	6
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_1388090 proquest_miscellaneous_67639055 proquest_miscellaneous_46860532 proquest_miscellaneous_17085353 pubmed_primary_16412488 crossref_citationtrail_10_1016_j_virol_2005_12_001 crossref_primary_10_1016_j_virol_2005_12_001 fao_agris_US201301069662 elsevier_sciencedirect_doi_10_1016_j_virol_2005_12_001 elsevier_clinicalkey_doi_10_1016_j_virol_2005_12_001
PublicationCentury	2000
PublicationDate	2006-02-20
PublicationDateYYYYMMDD	2006-02-20
PublicationDate_xml	– month: 02 year: 2006 text: 2006-02-20 day: 20
PublicationDecade	2000
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Virology (New York, N.Y.)
PublicationTitleAlternate	Virology
PublicationYear	2006
Publisher	Elsevier Inc
Publisher_xml	– name: Elsevier Inc
References	Oldstone, Lewicki, Homann, Nguyen, Julien, Gairin (bib14) 2001; 75 Salvato, Clegg, Buchmeier, Charrel, Gonzalez, Lukashevich, Peters, Rico-Hesse, Romanowski (bib18) 2005 Bredenbeek, Kooi, Lindenbach, Huijkman, Rice, Spaan (bib4) 2003; 84 Eichler, Lenz, Strecker, Eickmann, Klenk, Garten (bib5) 2003; 4 Gunther, Emmerich, Laue, Kuhle, Asper, Jung, Grewing, ter Meulen, Schmitz (bib8) 2000; 6 Peters, Jahrling, Liu, Kenyon, McKee, Oro (bib15) 1987; 134 Pushko, Geisbert, Parker, Jahrling, Smith (bib16) 2001; 75 Fisher-Hoch, McCormick (bib6) 2004; 3 McCormick, Fisher-Hoch (bib12) 2002; 262 Borio, Inglesby, Peters, Schmaljohn, Hughes, Jahrling, Ksiazek, Johnson, Meyerhoff, O'Toole, Ascher, Bartlett, Breman, Eitzen, Hamburg, Hauer, Henderson, Johnson, Kwik, Layton, Lillibridge, Nabel, Osterholm, Perl, Russell, Tonat (bib3) 2002; 287 Geisbert, Jones, Fritz, Shurtleff, Geisbert, Liebscher, Grolla, Stroher, Fernando, Daddario, Guttieri, Mothe, Larsen, Hensley, Jahrling, Feldmann (bib7) 2005; 2 McAllister, Arbetman, Mandl, Pena-Rossi, Andino (bib11) 2000; 74 Rodriguez-Carreno, Nelson, Botten, Smith-Nixon, Buchmeier, Whitton (bib17) 2005; 335 Monath (bib13) 2004 Bonaldo, Garratt, Marchevsky, Coutinho, Jabor, Almeida, Yamamura, Duarte, Oliveira, Lizeu, Camacho, Freire, Galler (bib2) 2005; 79 Lukashevich, Patterson, Carrion, Moshkoff, Ticer, Zapata, Brasky, Geiger, Hubbard, Bryant, Salvato (bib10) 2005; 79 ter Meulen, Badusche, Kuhnt, Doetze, Satoguina, Marti, Loeliger, Koulemou, Koivogui, Schmitz, Fleischer, Hoerauf (bib20) 2000; 74 Lenz, ter Meulen, Feldmann, Klenk, Garten (bib9) 2000; 74 Tao, Barba-Spaeth, Rai, Nussenzweig, Rice, Nussenzweig (bib19) 2005; 201 Barba-Spaeth, Longman, Albert, Rice (bib1) 2005; 202 Oldstone (10.1016/j.virol.2005.12.001_bib14) 2001; 75 Gunther (10.1016/j.virol.2005.12.001_bib8) 2000; 6 Lukashevich (10.1016/j.virol.2005.12.001_bib10) 2005; 79 Borio (10.1016/j.virol.2005.12.001_bib3) 2002; 287 Salvato (10.1016/j.virol.2005.12.001_bib18) 2005 Eichler (10.1016/j.virol.2005.12.001_bib5) 2003; 4 Barba-Spaeth (10.1016/j.virol.2005.12.001_bib1) 2005; 202 Pushko (10.1016/j.virol.2005.12.001_bib16) 2001; 75 Geisbert (10.1016/j.virol.2005.12.001_bib7) 2005; 2 Monath (10.1016/j.virol.2005.12.001_bib13) 2004 Tao (10.1016/j.virol.2005.12.001_bib19) 2005; 201 Fisher-Hoch (10.1016/j.virol.2005.12.001_bib6) 2004; 3 Lenz (10.1016/j.virol.2005.12.001_bib9) 2000; 74 McCormick (10.1016/j.virol.2005.12.001_bib12) 2002; 262 McAllister (10.1016/j.virol.2005.12.001_bib11) 2000; 74 Rodriguez-Carreno (10.1016/j.virol.2005.12.001_bib17) 2005; 335 Peters (10.1016/j.virol.2005.12.001_bib15) 1987; 134 ter Meulen (10.1016/j.virol.2005.12.001_bib20) 2000; 74 Bredenbeek (10.1016/j.virol.2005.12.001_bib4) 2003; 84 Bonaldo (10.1016/j.virol.2005.12.001_bib2) 2005; 79 11413293 - J Virol. 2001 Jul;75(14):6273-8 11689649 - J Virol. 2001 Dec;75(23):11677-85 15956601 - J Virol. 2005 Jul;79(13):8602-13 11987809 - Curr Top Microbiol Immunol. 2002;262:75-109 3034512 - Curr Top Microbiol Immunol. 1987;134:5-68 15971954 - PLoS Med. 2005 Jun;2(6):e183 16260489 - J Exp Med. 2005 Nov 7;202(9):1179-84 12692292 - J Gen Virol. 2003 May;84(Pt 5):1261-8 10998376 - Emerg Infect Dis. 2000 Sep-Oct;6(5):466-76 14555961 - EMBO Rep. 2003 Nov;4(11):1084-8 11988060 - JAMA. 2002 May 8;287(18):2391-405 15657290 - J Exp Med. 2005 Jan 17;201(2):201-9 10666248 - J Virol. 2000 Mar;74(5):2186-92 11070044 - J Virol. 2000 Dec;74(23):11418-21 16254329 - J Virol. 2005 Nov;79(22):13934-42 10982366 - J Virol. 2000 Oct;74(19):9197-205 15823608 - Virology. 2005 Apr 25;335(1):87-98
References_xml	– volume: 287 start-page: 2391 year: 2002 end-page: 2405 ident: bib3 article-title: Hemorrhagic fever viruses as biological weapons: medical and public health management publication-title: JAMA – volume: 4 start-page: 1084 year: 2003 end-page: 1088 ident: bib5 article-title: Identification of Lassa virus glycoprotein signal peptide as a publication-title: EMBO Rep. – start-page: 1095 year: 2004 end-page: 1176 ident: bib13 article-title: Yellow Fever Vaccine publication-title: Vaccines – volume: 75 start-page: 6273 year: 2001 end-page: 6278 ident: bib14 article-title: Common antiviral cytotoxic T-lymphocyte epitope for diverse arenaviruses publication-title: J. Virol. – volume: 335 start-page: 87 year: 2005 end-page: 98 ident: bib17 article-title: Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein publication-title: Virology – volume: 75 start-page: 11677 year: 2001 end-page: 11685 ident: bib16 article-title: Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses publication-title: J. Virol. – volume: 134 start-page: 5 year: 1987 end-page: 68 ident: bib15 article-title: Experimental studies of arenaviral hemorrhagic fevers publication-title: Curr. Top. Microbiol. Immunol. – volume: 74 start-page: 2186 year: 2000 end-page: 2192 ident: bib20 article-title: Characterization of human CD4+T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein publication-title: J. Virol. – volume: 79 start-page: 13934 year: 2005 end-page: 13942 ident: bib10 article-title: A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses publication-title: J. Virol. – volume: 79 start-page: 8602 year: 2005 end-page: 8613 ident: bib2 article-title: Attenuation of recombinant yellow fever 17D viruses expressing foreign protein epitopes at the surface publication-title: J. Virol. – volume: 2 start-page: 537 year: 2005 end-page: 545 ident: bib7 article-title: Development of a new vaccine for the prevention of Lassa fever publication-title: PLoS Med. – volume: 6 start-page: 466 year: 2000 end-page: 476 ident: bib8 article-title: Imported lassa fever in Germany: molecular characterization of a new lassa fever strain publication-title: Emerging Infect. Dis. – volume: 74 start-page: 9197 year: 2000 end-page: 9205 ident: bib11 article-title: Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases publication-title: J. Virol. – start-page: 725 year: 2005 end-page: 733 ident: bib18 article-title: Arenaviridae publication-title: Virus Taxonomy, VIIIth Report of the ICTV – volume: 262 start-page: 75 year: 2002 end-page: 109 ident: bib12 article-title: Lassa fever publication-title: Curr. Top. Microbiol. Immunol. – volume: 74 start-page: 11418 year: 2000 end-page: 11421 ident: bib9 article-title: Identification of a novel consensus sequence at the cleavage site of the lassa virus glycoprotein publication-title: J. Virol. – volume: 201 start-page: 201 year: 2005 end-page: 209 ident: bib19 article-title: Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model publication-title: J. Exp. Med. – volume: 3 start-page: 103 year: 2004 end-page: 111 ident: bib6 article-title: Lassa fever vaccine publication-title: Expert Rev. Vaccines – volume: 84 start-page: 1261 year: 2003 end-page: 1268 ident: bib4 article-title: A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication publication-title: J. Gen. Virol. – volume: 202 start-page: 1179 year: 2005 end-page: 1184 ident: bib1 article-title: Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes publication-title: J. Exp. Med. – volume: 74 start-page: 2186 issue: 5 year: 2000 ident: 10.1016/j.virol.2005.12.001_bib20 article-title: Characterization of human CD4+T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein publication-title: J. Virol. doi: 10.1128/JVI.74.5.2186-2192.2000 – volume: 74 start-page: 9197 issue: 19 year: 2000 ident: 10.1016/j.virol.2005.12.001_bib11 article-title: Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases publication-title: J. Virol. doi: 10.1128/JVI.74.19.9197-9205.2000 – volume: 84 start-page: 1261 issue: 5 year: 2003 ident: 10.1016/j.virol.2005.12.001_bib4 article-title: A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication publication-title: J. Gen. Virol. doi: 10.1099/vir.0.18860-0 – volume: 74 start-page: 11418 issue: 23 year: 2000 ident: 10.1016/j.virol.2005.12.001_bib9 article-title: Identification of a novel consensus sequence at the cleavage site of the lassa virus glycoprotein publication-title: J. Virol. doi: 10.1128/JVI.74.23.11418-11421.2000 – volume: 202 start-page: 1179 issue: 9 year: 2005 ident: 10.1016/j.virol.2005.12.001_bib1 article-title: Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes publication-title: J. Exp. Med. doi: 10.1084/jem.20051352 – volume: 287 start-page: 2391 issue: 18 year: 2002 ident: 10.1016/j.virol.2005.12.001_bib3 article-title: Hemorrhagic fever viruses as biological weapons: medical and public health management publication-title: JAMA doi: 10.1001/jama.287.18.2391 – volume: 75 start-page: 11677 issue: 23 year: 2001 ident: 10.1016/j.virol.2005.12.001_bib16 article-title: Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses publication-title: J. Virol. doi: 10.1128/JVI.75.23.11677-11685.2001 – volume: 79 start-page: 8602 issue: 13 year: 2005 ident: 10.1016/j.virol.2005.12.001_bib2 article-title: Attenuation of recombinant yellow fever 17D viruses expressing foreign protein epitopes at the surface publication-title: J. Virol. doi: 10.1128/JVI.79.13.8602-8613.2005 – volume: 3 start-page: 103 issue: 2 year: 2004 ident: 10.1016/j.virol.2005.12.001_bib6 article-title: Lassa fever vaccine publication-title: Expert Rev. Vaccines doi: 10.1586/14760584.3.2.189 – start-page: 725 year: 2005 ident: 10.1016/j.virol.2005.12.001_bib18 article-title: Arenaviridae – volume: 262 start-page: 75 year: 2002 ident: 10.1016/j.virol.2005.12.001_bib12 article-title: Lassa fever publication-title: Curr. Top. Microbiol. Immunol. – volume: 2 start-page: 537 issue: 6 year: 2005 ident: 10.1016/j.virol.2005.12.001_bib7 article-title: Development of a new vaccine for the prevention of Lassa fever publication-title: PLoS Med. doi: 10.1371/journal.pmed.0020183 – volume: 134 start-page: 5 year: 1987 ident: 10.1016/j.virol.2005.12.001_bib15 article-title: Experimental studies of arenaviral hemorrhagic fevers publication-title: Curr. Top. Microbiol. Immunol. – start-page: 1095 year: 2004 ident: 10.1016/j.virol.2005.12.001_bib13 article-title: Yellow Fever Vaccine – volume: 75 start-page: 6273 issue: 14 year: 2001 ident: 10.1016/j.virol.2005.12.001_bib14 article-title: Common antiviral cytotoxic T-lymphocyte epitope for diverse arenaviruses publication-title: J. Virol. doi: 10.1128/JVI.75.14.6273-6278.2001 – volume: 6 start-page: 466 issue: 5 year: 2000 ident: 10.1016/j.virol.2005.12.001_bib8 article-title: Imported lassa fever in Germany: molecular characterization of a new lassa fever strain publication-title: Emerging Infect. Dis. doi: 10.3201/eid0605.000504 – volume: 335 start-page: 87 issue: 1 year: 2005 ident: 10.1016/j.virol.2005.12.001_bib17 article-title: Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein publication-title: Virology doi: 10.1016/j.virol.2005.01.019 – volume: 201 start-page: 201 issue: 2 year: 2005 ident: 10.1016/j.virol.2005.12.001_bib19 article-title: Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model publication-title: J. Exp. Med. doi: 10.1084/jem.20041526 – volume: 4 start-page: 1084 issue: 11 year: 2003 ident: 10.1016/j.virol.2005.12.001_bib5 article-title: Identification of Lassa virus glycoprotein signal peptide as a trans-acting maturation factor publication-title: EMBO Rep. doi: 10.1038/sj.embor.7400002 – volume: 79 start-page: 13934 issue: 22 year: 2005 ident: 10.1016/j.virol.2005.12.001_bib10 article-title: A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses publication-title: J. Virol. doi: 10.1128/JVI.79.22.13934-13942.2005 – reference: 16260489 - J Exp Med. 2005 Nov 7;202(9):1179-84 – reference: 12692292 - J Gen Virol. 2003 May;84(Pt 5):1261-8 – reference: 15823608 - Virology. 2005 Apr 25;335(1):87-98 – reference: 15956601 - J Virol. 2005 Jul;79(13):8602-13 – reference: 16254329 - J Virol. 2005 Nov;79(22):13934-42 – reference: 10666248 - J Virol. 2000 Mar;74(5):2186-92 – reference: 11413293 - J Virol. 2001 Jul;75(14):6273-8 – reference: 11689649 - J Virol. 2001 Dec;75(23):11677-85 – reference: 3034512 - Curr Top Microbiol Immunol. 1987;134:5-68 – reference: 11987809 - Curr Top Microbiol Immunol. 2002;262:75-109 – reference: 10982366 - J Virol. 2000 Oct;74(19):9197-205 – reference: 10998376 - Emerg Infect Dis. 2000 Sep-Oct;6(5):466-76 – reference: 15971954 - PLoS Med. 2005 Jun;2(6):e183 – reference: 15657290 - J Exp Med. 2005 Jan 17;201(2):201-9 – reference: 11988060 - JAMA. 2002 May 8;287(18):2391-405 – reference: 11070044 - J Virol. 2000 Dec;74(23):11418-21 – reference: 14555961 - EMBO Rep. 2003 Nov;4(11):1084-8
SSID	ssj0004770
Score	2.1951048
Snippet	The Yellow Fever Vaccine 17D (YFV17D) has been used as a vector for the Lassa virus glycoprotein precursor (LASV-GPC) resulting in construction of...
SourceID	pubmedcentral proquest pubmed crossref fao elsevier
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	299
SubjectTerms	Animals genetic vectors glycoproteins Glycoproteins - genetics Glycoproteins - metabolism Guinea Pigs human health Humans Lassa Fever - prevention & control Lassa mammarenavirus Lassa virus Lassa virus - genetics Lassa virus - immunology Lassa virus - metabolism recombinant fusion proteins Recombinant vaccine vaccines Vaccines, Synthetic - administration & dosage Vaccines, Synthetic - genetics Vaccines, Synthetic - metabolism viral antibodies viral proteins Viral Vaccines - administration & dosage Viral Vaccines - genetics Viral Vaccines - metabolism Yellow and Lassa Fevers yellow fever Yellow Fever - prevention & control Yellow Fever Vaccine - administration & dosage Yellow Fever Vaccine - genetics Yellow Fever Vaccine - metabolism Yellow fever virus Yellow fever virus - immunology YFV17D vaccine
Title	A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins
URI	https://www.clinicalkey.com/#!/content/1-s2.0-S0042682205008032 https://dx.doi.org/10.1016/j.virol.2005.12.001 https://www.ncbi.nlm.nih.gov/pubmed/16412488 https://www.proquest.com/docview/17085353 https://www.proquest.com/docview/46860532 https://www.proquest.com/docview/67639055 https://pubmed.ncbi.nlm.nih.gov/PMC1388090
Volume	345
WOSCitedRecordID	wos000235468300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1096-0341 dateEnd: 20210102 omitProxy: false ssIdentifier: ssj0004770 issn: 0042-6822 databaseCode: AIEXJ dateStart: 19950110 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb5swFLaSdpP2Mu3aZpeOh70xqmDAhsesF22dWlVaW2VPyBi7o01IlNuaX7G_vGNsCEmb7iLtBUXEJwTOx_Hn43NB6H1EQl-6InSEh2GBIpPQYTRQkVMME49RTELdbIKenITdbnTaaPwsc2FmPZrn4c1NNPyvqoZzoGyVOvsX6q5-FE7AZ1A6HEHtcPwjxXdstcjtJ0WIi_1Nba78sA8F3Ift0n17xrjaS1el_YsQWJXkBASa2bNsNB3bl705HxTFGzLjxzPM9SIb6XJNd7TvqbkTPo5EqoLGxHUV_Wsf7VZqVVEA16w_XMnp1_v3TDtjlQtoDkLHldi-mCY6muAiy3kZqlPzVWAHt-v218cOCfGS_fV0PUkDNFy3prp3kpmYPd2n-JbN1-6Hq12VF9jTXjLl4NU-kprCh_1C47A-BE6jewmulNo-Pd5zVXGcqN1Em5gGEZjJzc7ng-7RItWW0iqrSd1IWciqCBm89Q9USVpzuXW8pynZ4K7VzWqQbo31nD1Bj81yxepomD1FDZE_Qw91A9P5c_SlY9XAZmmwWQXYLACbZcBmLcBmFWCzCrBZS2B7gc4PD872PjmmPYfDgdRNHA7M06eChMTlvsQu3CcNQ4aDFCgi9XAiQuJxLkXAiZQBTlzp0UAy6SYiSoH6v0Qb-SAX28hKmEjTlDMOBNKnzEsYjbgnUyGjKImo10K4fHgxN7XrVQuVXlwGKV7FxcNXXVWD2MUqVLOFPlRCQ1265f7hfqmVuMxKhnk0BpjdL0YqMUNaNRn9veA2qD5mlzCZx-dfsQohcNskIgS30LsSDzFYe7WFx3IxmI5jl8ISyQu89SN80Ifq9rJ-BAFKEbWDoIW2NMIWT8dgtYXoEvaqAaoW_fI3efa9qElv3ptX_yz5Gj1aWIw3aGMymoq36AGfTbLxaAc1aTfcMS_jL5EyAyk
linkProvider	Elsevier
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+recombinant+Yellow+Fever+17D+vaccine+expressing+Lassa+virus+glycoproteins&rft.jtitle=Virology+%28New+York%2C+N.Y.%29&rft.au=Bredenbeek%2C+Peter+J.&rft.au=Molenkamp%2C+Richard&rft.au=Spaan%2C+Willy+J.M.&rft.au=Deubel%2C+Vincent&rft.date=2006-02-20&rft.issn=0042-6822&rft.volume=345&rft.issue=2&rft.spage=299&rft.epage=304&rft_id=info:doi/10.1016%2Fj.virol.2005.12.001&rft_id=info%3Apmid%2F16412488&rft.externalDocID=PMC1388090
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0042-6822&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0042-6822&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0042-6822&client=summon